
The FDA granted RMAT and fast track designations to prizloncabtagene autoleucel , a CD20/CD19 bispecific CAR T-cell therapy, for relapsed/refractory large B-cell lymphoma.
Classical Hodgkin Lymphoma: Is There a Cure?
A 22-Year-Old Woman With Stage IV Classical Hodgkin Lymphoma
History & Physical
Laboratory Values
Staging PET/CT
Pathology
Treatment:A(BV)VD x 6

